小圆细胞肉瘤瘤生物库显示CIC::DUX4肉瘤对MCL-1抑制的脆弱性
Femke C A S Ringnalda1,2, Gijs J F van Son1,2, Laurens H G Verweij1,2
1Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Nature communications
|August 21, 2025
概括
一个新的儿科小圆细胞肉瘤 (SRCS) 瘤生物库保留了瘤特征,并揭示了实体特异性药物敏感性,为癌症研究和药物发现提供了有希望的资源.
科学领域:
- 癌症学
- 癌症生物学
- 遗传学
背景情况:
- 小圆细胞瘤 (SRCS) 是具有有限的非尤文瘤亚型的临床前模型的侵袭性儿科瘤.
- 目前对SRCS的治疗方案是标准化的,尽管基因和病理不同.
- 现有的细胞系和异种移植模型不足以研究各种SRCS的异质性.
研究的目的:
- 建立和描述儿科小圆细胞肉瘤 (SRCS) 患者衍生的瘤生物库.
- 评估瘤模型对患者瘤特征的准确性,包括遗传学和异质性.
- 用瘤模型进行药物查,并确定特定SRCS实体的潜在向治疗方法.
主要方法:
- 从儿童SRCS患者样本中开发长期瘤培养物,具有多种转位.
- 组织学分析,全基因组测序和RNA测序以验证瘤的真实性.
- 将瘤突变群与患者纵向样本进行比较,以评估细胞异质性.
- 在已建立的瘤模型上使用细胞毒性和向化合物的药物查.
主要成果:
- 瘤生物库成功地保持了患者瘤的组织特征,基因表达标记和染色体重排.
- 瘤精确地反映了患者纵向样本中观察到的细胞异质性.
- 药物查发现了实体特异性敏感性,包括CIC:: DUX4肉瘤的MCL- 1抑制剂.
结论:
- 已建立的SRCS瘤生物库是临床前研究的宝贵资源.
- 瘤为研究SRCS生物学和异质性提供了一个可靠的平台.
- 这种资源使得有效的药物查成为可能,为SRCS个性化治疗策略铺平了道路.
相关概念视频
02:34Inhibition of Cdk Activity
4.9K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
02:23Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K